BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37792547)

  • 1. Multimodal Imaging-Guided Photoimmunotherapy of Pancreatic Cancer by Organosilica Nanomedicine.
    Zhang H; Chen K; Guo K; Tao J; Song L; Ren S; Zhao Y; Teng Z; Qiu W; Wang Z
    Adv Healthc Mater; 2024 Jan; 13(2):e2302195. PubMed ID: 37792547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic interventional photothermal therapy and immunotherapy using an iron oxide nanoplatform for the treatment of pancreatic cancer.
    Wang M; Li Y; Wang M; Liu K; Hoover AR; Li M; Towner RA; Mukherjee P; Zhou F; Qu J; Chen WR
    Acta Biomater; 2022 Jan; 138():453-462. PubMed ID: 34757232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multifunctional nanoparticles precisely reprogram the tumor microenvironment and potentiate antitumor immunotherapy after near-infrared-II light-mediated photothermal therapy.
    Ge Y; Zhang J; Jin K; Ye Z; Wang W; Zhou Z; Ye J
    Acta Biomater; 2023 Sep; 167():551-563. PubMed ID: 37302731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-delivery of metal-coordinated NIR-II nanoadjuvants for multimodal imaging-guided photothermal-chemodynamic amplified immunotherapy.
    Dai Y; Li X; Xue Y; Chen K; Jiao G; Zhu L; Li M; Fan Q; Dai Y; Zhao Q; Shen Q
    Acta Biomater; 2023 Aug; 166():496-511. PubMed ID: 37230439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapeutic drug-photothermal agent co-self-assembling nanoparticles for near-infrared fluorescence and photoacoustic dual-modal imaging-guided chemo-photothermal synergistic therapy.
    Li Y; Liu G; Ma J; Lin J; Lin H; Su G; Chen D; Ye S; Chen X; Zhu X; Hou Z
    J Control Release; 2017 Jul; 258():95-107. PubMed ID: 28501673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A light-controllable specific drug delivery nanoplatform for targeted bimodal imaging-guided photothermal/chemo synergistic cancer therapy.
    Guo Y; Wang XY; Chen YL; Liu FQ; Tan MX; Ao M; Yu JH; Ran HT; Wang ZX
    Acta Biomater; 2018 Oct; 80():308-326. PubMed ID: 30240955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photothermally activatable PDA immune nanomedicine combined with PD-L1 checkpoint blockade for antimetastatic cancer photoimmunotherapy.
    Lu Q; Qi S; Li P; Yang L; Yang S; Wang Y; Cheng Y; Song Y; Wang S; Tan F; Li N
    J Mater Chem B; 2019 Apr; 7(15):2499-2511. PubMed ID: 32255127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metal-organic framework-mediated multifunctional nanoparticles for combined chemo-photothermal therapy and enhanced immunotherapy against colorectal cancer.
    Liu H; Xu C; Meng M; Li S; Sheng S; Zhang S; Ni W; Tian H; Wang Q
    Acta Biomater; 2022 May; 144():132-141. PubMed ID: 35307591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous oxygen generating multifunctional theranostic nanoplatform for enhanced photodynamic-photothermal therapy and multimodal imaging.
    Wu K; Zhao H; Sun Z; Wang B; Tang X; Dai Y; Li M; Shen Q; Zhang H; Fan Q; Huang W
    Theranostics; 2019; 9(25):7697-7713. PubMed ID: 31695795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multifunctional theranostic nanoparticles for multi-modal imaging-guided CAR-T immunotherapy and chemo-photothermal combinational therapy of non-Hodgkin's lymphoma.
    Shi B; Li D; Yao W; Wang W; Jiang J; Wang R; Yan F; Liu H; Zhang H; Ye J
    Biomater Sci; 2022 May; 10(10):2577-2589. PubMed ID: 35393988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-delivery of nanoparticle and molecular drug by hollow mesoporous organosilica for tumor-activated and photothermal-augmented chemotherapy of breast cancer.
    Zhang H; Song F; Dong C; Yu L; Chang C; Chen Y
    J Nanobiotechnology; 2021 Sep; 19(1):290. PubMed ID: 34579711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biodegradable hollow mesoporous organosilica nanotheranostics (HMONs) as a versatile platform for multimodal imaging and phototherapeutic-triggered endolysosomal disruption in ovarian cancer.
    Li P; Lin B; Chen Z; Liu P; Liu J; Li W; Liu P; Guo Z; Chen C
    Drug Deliv; 2022 Dec; 29(1):161-173. PubMed ID: 34967262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual-Stimuli Responsive Nanotheranostics for Multimodal Imaging Guided Trimodal Synergistic Therapy.
    Fang S; Lin J; Li C; Huang P; Hou W; Zhang C; Liu J; Huang S; Luo Y; Fan W; Cui D; Xu Y; Li Z
    Small; 2017 Feb; 13(6):. PubMed ID: 27862953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multimodal Imaging-Guided Photothermal Immunotherapy Based on a Versatile NIR-II Aggregation-Induced Emission Luminogen.
    Yan D; Wang M; Wu Q; Niu N; Li M; Song R; Rao J; Kang M; Zhang Z; Zhou F; Wang D; Tang BZ
    Angew Chem Int Ed Engl; 2022 Jul; 61(27):e202202614. PubMed ID: 35344252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor microenvironment-responsive versatile "Trojan horse" theranostic nanoplatform for magnetic resonance imaging-guided multimodal synergistic antitumor treatment.
    Huang Q; Pan Y; Wang M; Liu Z; Chen H; Wang J; Zhao Z; Zhang Y
    Acta Biomater; 2022 Jul; 147():270-286. PubMed ID: 35595202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemo-photodynamic therapy with light-triggered disassembly of theranostic nanoplatform in combination with checkpoint blockade for immunotherapy of hepatocellular carcinoma.
    Xu J; Zheng Q; Cheng X; Hu S; Zhang C; Zhou X; Sun P; Wang W; Su Z; Zou T; Song Z; Xia Y; Yi X; Gao Y
    J Nanobiotechnology; 2021 Oct; 19(1):355. PubMed ID: 34717654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor Cell Targeting and Responsive Nanoplatform for Multimodal-Imaging Guided Chemodynamic/Photodynamic/Photothermal Therapy toward Triple Negative Breast Cancer.
    Li L; Li J; Hu R; Zhang X; Ding L; Ren G; Liu W; Wang H; Wang B; Zhang C; Diao H
    ACS Appl Mater Interfaces; 2023 Jun; 15(23):27706-27718. PubMed ID: 37261936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single-beam of light priming the immune responses and boosting cancer photoimmunotherapy.
    Sun Y; Han R; Wang J; Qin Y; Ren Z; Feng X; Liu Q; Wang X
    J Control Release; 2022 Oct; 350():734-747. PubMed ID: 36063959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hybrid FeWO
    Yang C; Che X; Zhang Y; Gu D; Dai G; Shu J; Yang L
    Int J Nanomedicine; 2023; 18():8023-8037. PubMed ID: 38164263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Merging metal organic framework with hollow organosilica nanoparticles as a versatile nanoplatform for cancer theranostics.
    Chen L; Zhang J; Zhou X; Yang S; Zhang Q; Wang W; You Z; Peng C; He C
    Acta Biomater; 2019 Mar; 86():406-415. PubMed ID: 30625415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.